|
|
|
|
Aging, Metabolics & Weight Studies at IAS 2024
|
|
|
110 reports
IAS
25th International AIDS Conference
22 to 26 July 2024
IAS: Peripheral blood and cerebrospinal fluid viremia of 24-weeks MONOtherapy of DOlutegravir in HIV-1 virologically suppressed patients: MONODO study - (08/10/17)  
Negative Perception of Self & Stigma & Depression associated with Worse Expectations of Aging in Brazil -
(08/26/24)  
Weight Gain and Health-Related Quality of Life in PWH on ART -
(08/06/24)  
Fine Differences Among Five Anal Cancer Screening Strategies in HIV Group - Mark Mascolini (07/30/24)  
Prevalence of high risk penile human papillomavirus in men who have sex with men (MSM) and transgender women (TGW) - (07/30/24)  
Fine Differences Among Five Anal Cancer Screening Strategies in HIV Group - Mark Mascolini (07/30/24)  
Efficacy and safety of bictegravir plus lenacapavir: 48-week outcomes in virologically suppressed people with HIV-1 on complex antiretroviral regimens at baseline - (07/27/24)  
Changes in body mass index before and after starting dolutegravir and compared to protease inhibitors in children and adolescents living with HIV in Europe and Thailand -
(08/03/24)  
Additional Time PostIntegrase Inhibitor to Protease Inhibitor Switch Shows Trend to Weight Loss: DEFINE 48-week Results - (07/27/24)  
Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial. - (07/27/24)  
No Confirmed Virological Failures (CVF) for 144 Weeks When Switching 2-/3-/4-Drug ART to DTG/3TC in Heavily Treatment-Experienced PLWHA with Prior M184V/I and Multiple Virological Failures in the Prospective SOLAR-3D Study - (07/24/24)  
Switching to B/F/TAF in a Real-World Cohort of Older People
With HIV and a High Burden of Non-AIDS-Related Comorbidities - (07/30/24)  
PAIRED - PAtIent Reported Experiences and perceiveD Benefit of Treatment With Dolutegravir/Lamivudine (DTG/3TC) - Qualitative Interviews: Diverse Group of People With HIV-1 (PWH) Reflect on Life and Health -
(08/03/24)  
TOPICS at IAS
Bone disease, HIGH rates of frailty at ages 2 decades earlier for PWH, frailty & falls & polypharmacy all associated, multimorbidities, geriatric syndromes & assessments, aging for perinatal acquired HIV, polypharmacy, hypertension & dementia, heart disease, and aging in numerous countries outside of the Western World.
Multimorbidity by sex at birth among ageing (65 years and older) persons with HIV (PWH) in the Southern United States (US) - (07/28/24) for PWH >65 at UNC high rates of mutimorbidities & higher rates of specific comornorbities for women with HIV.
Negative Perception of Self & Stigma & Depression associated with Worse Expectations of Aging in Brazil -
(08/26/24)  
Bone health in Malaysian women living with HIV: uncovering the pores in osteoporosis screening and management in a high-risk population - (08/05/24) PWH are simply NOT getting screened for bone disease, bone mineral density test in USA or Malaysia
Low Compliance (10%) with Bone Mineral Density Screening Recommendations for People with HIV Despite High Fracture Rates...."critical to prioritize health screenings" (08/04/24)
Time is of the essence: clinical frailty among a cohort of Indigenous peoples aging with HIV in Ontario, Canada - (08/03/24)
Vitamin D Plus Calcium Improves Bone Density in HIV Youth Who Start With Low Density - (07/28/24) study suggests taking Vit D + calcium in HIV+ youth with low bone density might increase bone strength.
Randomised placebo-controlled trial of high-dose vitamin D and low-dose calcium supplementation to improve bone density in adolescents with perinatally-acquired HIV in Southern Africa - (07/28/24)
Detailed modelling of viremia exposure does not independently predict cardiovascular disease in people with HIV - (07/28/24)
An assessment of clinical frailty and early aging among a cohort of people living with HIV in Ontario, Canada....41% prefrailty (age 44), 6% frailty (age 55): indicators of frailty & prefrailty; IDU history increased risk, previous AIDS increased risk - (08/03/24) HIGH FRAILTY rates, IDU history is risk factor.
Geriatric syndromes and quality of life in older adults living with HIV in Brazil....50% Pre-frail, 6% frail....age 62, CD4 700+, 90% undetectable viral load....greater services needed ! - (08/03/24) HIGH RATES OF FRAILTY. And numerous specific comorbidities.
Polypharmacy Contributes to Frailty & Falls - CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a Canadian cohort of people aged 65 and older living with HIV....53% of older PWH have frailty- (08/01/24) POLYPHARMACY, FALLS & FRAILTY ALL ASSOCIATED.
Hypertension management and risk of dementia in people with and without HIV infection - (08/01/24)
What drives Comorbidities in PWH Highlights From Aging Pre-Conference Talks, at AIDS 2024 - (07/31/24)
Risk of major cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: retrospective cohort analyses using routine, de-identified data from South Africa - (07/28/24)
Unruly Natural Killer Cells May Figure in CVD Risk in HIV+ Adolescents - (08/02/24)
Increased cardiovascular risk in perinatally HIV-acquired adolescents (PHIV) may linked to proinflammatory NK cells - (07/31/24)
Increased biomarkers of cardiovascular disease in a long-term survivor cohort of young adults living with perinatal HIV with virologic non-suppression or metabolic syndrome - (07/28/24)
Three CVD Markers High in 347 Young Adults With HIV in Thailand - (07/28/24)
An assessment of clinical frailty and early aging among a cohort of people living with HIV in Ontario, Canada - (08/01/24)
Comprehensive geriatric assessment for people living with HIV and frailty: a feasibility randomized controlled trial - (08/01/24) PROVING COMPREHENSIVE GERIATRIC ASSESSMENTS IS FEASIBLE & WELCOME BY PWH
Perceptions on frailty and frailty screening of people living with HIV and their healthcare professionals in Ethiopia: a qualitative study - (08/01/24)
Frailty and multimorbidity in mid-aged and older adults living with HIV: a cross-sectional study in Zimbabwe - (08/01/24)
Assessing Comorbid Conditions in HIV/AIDS Patients: Insights from the CHAO (Comorbidities of HIV/AIDS Outpatients) Study in Meru County, Kenya and Their Role in Shaping Integrated Health Care Approaches - (07/31/24)
Prevalence and associated factors of chronic kidney disease in young people living with HIV in Uganda - (07/31/24)
Neurocognitive trajectories among a young adult cohort from four African countries: associations with HIV and food insecurity - (07/28/24)
Integrating non-communicable disease screening and treatment in antiretroviral clinics: insights from Malawi - (07/28/24)
|
|
|
|
|
|
|